Rebecca A. Nace

828 total citations
30 papers, 634 citations indexed

About

Rebecca A. Nace is a scholar working on Genetics, Epidemiology and Animal Science and Zoology. According to data from OpenAlex, Rebecca A. Nace has authored 30 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Genetics, 13 papers in Epidemiology and 8 papers in Animal Science and Zoology. Recurrent topics in Rebecca A. Nace's work include Virus-based gene therapy research (25 papers), Animal Virus Infections Studies (8 papers) and Virology and Viral Diseases (7 papers). Rebecca A. Nace is often cited by papers focused on Virus-based gene therapy research (25 papers), Animal Virus Infections Studies (8 papers) and Virology and Viral Diseases (7 papers). Rebecca A. Nace collaborates with scholars based in United States, Germany and France. Rebecca A. Nace's co-authors include Stephen J. Russell, Glen N. Barber, Shruthi Naik, Elizabeth J. Kelly, Mark J. Federspiel, K-W Peng, Lianwen Zhang, Kah Whye Peng, Miguel Ángel Muñoz-Alía and Danielle N. Yarde and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Rebecca A. Nace

29 papers receiving 622 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rebecca A. Nace United States 16 487 250 229 164 152 30 634
Markus Hörer Germany 9 447 0.9× 167 0.7× 316 1.4× 149 0.9× 64 0.4× 15 581
Sascha Bossow Germany 16 763 1.6× 421 1.7× 388 1.7× 289 1.8× 234 1.5× 32 1.1k
Marilyn Fernandez United States 9 308 0.6× 139 0.6× 181 0.8× 168 1.0× 147 1.0× 17 569
Serena Bonifati United States 14 224 0.5× 151 0.6× 240 1.0× 109 0.7× 57 0.4× 18 594
Hanni Uusi-Kerttula United Kingdom 12 268 0.6× 147 0.6× 245 1.1× 134 0.8× 94 0.6× 15 569
K-W Peng United States 13 590 1.2× 301 1.2× 291 1.3× 178 1.1× 189 1.2× 14 689
Sonia Wennier United States 11 230 0.5× 136 0.5× 99 0.4× 104 0.6× 48 0.3× 13 388
Lisa A. Santry Canada 14 157 0.3× 140 0.6× 191 0.8× 90 0.5× 41 0.3× 23 472
Jacqueline F. Spencer United States 20 925 1.9× 515 2.1× 590 2.6× 228 1.4× 39 0.3× 35 1.1k
Marko Marttila Sweden 7 506 1.0× 206 0.8× 336 1.5× 143 0.9× 41 0.3× 8 624

Countries citing papers authored by Rebecca A. Nace

Since Specialization
Citations

This map shows the geographic impact of Rebecca A. Nace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecca A. Nace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecca A. Nace more than expected).

Fields of papers citing papers by Rebecca A. Nace

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rebecca A. Nace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecca A. Nace. The network helps show where Rebecca A. Nace may publish in the future.

Co-authorship network of co-authors of Rebecca A. Nace

This figure shows the co-authorship network connecting the top 25 collaborators of Rebecca A. Nace. A scholar is included among the top collaborators of Rebecca A. Nace based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebecca A. Nace. Rebecca A. Nace is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Haifei, et al.. (2024). Oncolytic cytomegaloviruses expressing EGFR-retargeted fusogenic glycoprotein complex and drug-controllable interleukin 12. Cell Reports Medicine. 6(1). 101874–101874. 4 indexed citations
2.
Tonne, Jason M., Jill Thompson, Rebecca A. Nace, et al.. (2024). Smoldering oncolysis by foamy virus carrying CD19 as a CAR target escapes CAR T detection by genomic modification. SHILAP Revista de lepidopterología. 32(3). 200852–200852. 2 indexed citations
3.
Jiang, Haifei, Rebecca A. Nace, Nandakumar Packiriswamy, et al.. (2023). Oncolytic α-herpesvirus and myeloid-tropic cytomegalovirus cooperatively enhance systemic antitumor responses. Molecular Therapy. 32(1). 241–256. 2 indexed citations
4.
Nace, Rebecca A., et al.. (2022). Evaluation of the stability and intratumoral delivery of foreign transgenes encoded by an oncolytic Foamy Virus vector. Cancer Gene Therapy. 29(8-9). 1240–1251. 7 indexed citations
5.
Nace, Rebecca A., et al.. (2022). Polycytidine tract deletion from microRNA-detargeted oncolytic Mengovirus optimizes the therapeutic index in a murine multiple myeloma model. Molecular Therapy — Oncolytics. 28. 15–30. 2 indexed citations
6.
Muñoz-Alía, Miguel Ángel, Rebecca A. Nace, Lianwen Zhang, & Stephen J. Russell. (2021). Serotypic evolution of measles virus is constrained by multiple co-dominant B cell epitopes on its surface glycoproteins. Cell Reports Medicine. 2(4). 100225–100225. 28 indexed citations
7.
Nace, Rebecca A., et al.. (2021). MicroRNA-detargeting proves more effective than leader gene deletion for improving safety of oncolytic Mengovirus in a nude mouse model. Molecular Therapy — Oncolytics. 23. 1–13. 6 indexed citations
8.
Muñoz-Alía, Miguel Ángel, Rebecca A. Nace, Alexander Tischer, et al.. (2021). MeV-Stealth: A CD46-specific oncolytic measles virus resistant to neutralization by measles-immune human serum. PLoS Pathogens. 17(2). e1009283–e1009283. 17 indexed citations
9.
Nace, Rebecca A., et al.. (2020). Oncolytic Activity of Targeted Picornaviruses Formulated as Synthetic Infectious RNA. Molecular Therapy — Oncolytics. 17. 484–495. 14 indexed citations
10.
Nace, Rebecca A., et al.. (2019). Generation of a Tumor-Specific Chemokine Gradient Using Oncolytic Vesicular Stomatitis Virus Encoding CXCL9. Molecular Therapy — Oncolytics. 16. 63–74. 34 indexed citations
11.
Zhang, Lianwen, Marshall D. Behrens, Rebecca A. Nace, et al.. (2016). Robust Oncolytic Virotherapy Induces Tumor Lysis Syndrome and Associated Toxicities in the MPC-11 Plasmacytoma Model. Molecular Therapy. 24(12). 2109–2117. 17 indexed citations
12.
Ruiz, Autumn, Elizabeth M. Hadac, Rebecca A. Nace, & Stephen J. Russell. (2016). MicroRNA-Detargeted Mengovirus for Oncolytic Virotherapy. Journal of Virology. 90(8). 4078–4092. 32 indexed citations
13.
Miller, Amber, et al.. (2015). Perfusion Pressure Is a Critical Determinant of the Intratumoral Extravasation of Oncolytic Viruses. Molecular Therapy. 24(2). 306–317. 25 indexed citations
14.
Miller, Amber, Lukkana Suksanpaisan, Shruthi Naik, et al.. (2014). Reporter gene imaging identifies intratumoral infection voids as a critical barrier to systemic oncolytic virus efficacy. Molecular Therapy — Oncolytics. 1. 14005–14005. 24 indexed citations
15.
Yarde, Danielle N., Rebecca A. Nace, & Stephen J. Russell. (2013). Oncolytic vesicular stomatitis virus and bortezomib are antagonistic against myeloma cells in vitro but have additive anti-myeloma activity in vivo. Experimental Hematology. 41(12). 1038–1049. 27 indexed citations
16.
Nakashima, Hiroshi, et al.. (2013). HSV-NIS, an oncolytic herpes simplex virus type 1 encoding human sodium iodide symporter for preclinical prostate cancer radiovirotherapy. Cancer Gene Therapy. 20(8). 478–485. 32 indexed citations
17.
Tobin, Gregory J., Linh Pham, Rebecca A. Nace, et al.. (2013). Epitope Dampening Monotypic Measles Virus Hemagglutinin Glycoprotein Results in Resistance to Cocktail of Monoclonal Antibodies. PLoS ONE. 8(1). e52306–e52306. 18 indexed citations
18.
Bailey, Kent R., Shruthi Naik, Rebecca A. Nace, et al.. (2013). Mathematical Model for Radial Expansion and Conflation of Intratumoral Infectious Centers Predicts Curative Oncolytic Virotherapy Parameters. PLoS ONE. 8(9). e73759–e73759. 27 indexed citations
19.
Yarde, Danielle N., Shruthi Naik, Rebecca A. Nace, et al.. (2013). Meningeal myeloma deposits adversely impact the therapeutic index of an oncolytic VSV. Cancer Gene Therapy. 20(11). 616–621. 13 indexed citations
20.
Naik, Shruthi, Rebecca A. Nace, Mark J. Federspiel, et al.. (2012). Curative one-shot systemic virotherapy in murine myeloma. Leukemia. 26(8). 1870–1878. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Markus Hörer Breakdown of academic impact, for papers by Sascha Bossow Breakdown of academic impact, for papers by Marilyn Fernandez Breakdown of academic impact, for papers by Serena Bonifati Breakdown of academic impact, for papers by Hanni Uusi-Kerttula Breakdown of academic impact, for papers by K-W Peng Breakdown of academic impact, for papers by Sonia Wennier Breakdown of academic impact, for papers by Lisa A. Santry Breakdown of academic impact, for papers by Jacqueline F. Spencer Breakdown of academic impact, for papers by Marko Marttila
Rankless by CCL
2026